C12Y 603/05
Carbon-nitrogen ligases with glutamine as amido-n-donor
Official title: Carbon-nitrogen ligases with glutamine as amido-N-donor (6.3.5)
C12Y603/05 (Carbon-nitrogen ligases with glutamine as amido-n-donor) appears on 23 US grants and 34 published applications in this corpus.
Search patents in C12Y- Granted patents
- 23
- Published applications
- 34
- Assignees
- 32
- Inventors
- 101
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 2 | 4 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 2 | 3 |
| 2023 | 0 | 3 |
| 2024 | 4 | 1 |
| 2025 | 0 | 5 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 603/05005Carbamoyl-phosphate synthase10
- C12Y 603/05001Nad+ synthase5
- C12Y 603/05002Gmp synthase , i.e. glutamine amidotransferase2
- C12Y 603/05004Asparagine synthase2
- C12Y 603/05011Cobyrinate a,c-diamide synthase2
- C12Y 603/05006Asparaginyl-trna synthase1
- C12Y 603/05007Glutaminyl-trna synthase1
- C12Y 603/05003Phosphoribosylformylglycinamidine synthase0
All 10 subgroupsShow fewer
Recent patents
- Glutamine-hydrolyzing GMP synthase variant and method for producing purine nucleotide by using same1 Sep 2026US 12,723,242 B2Cj Cheiljedang Corporation
- Gene engineering bacteria for producing L-arginine and construction method and application of gene engineering bacteria10 Mar 2026US 12,571,013 B2Ningxia Eppen Biotech Co., Ltd
- Compositions and uses thereof27 Jan 2026US 12,533,392 B2SkinBio Therapeutics PLC
- Genetically engineered bacteria, its construction method and its application in producing NAD+ method24 Dec 2024US 12,173,338 B2Hefei Knature Bio-Pharm Co., Ltd.
- Engineered parasites for delivering protein to the central nervous system (CNS)27 Aug 2024US 12,070,476 B2Ramot at Tel-Aviv University Ltd.
- A novel marker for cardiomyocytes dedifferentiation13 Aug 2026US 2026/0235604 A1National University of Singapore
- Compositions and uses thereof16 Jul 2026US 2026/0199428 A1Skinbiotherapeutics PLC
- Metabolic selection via the serine biosynthesis pathway26 Mar 2026US 2026/0085327 A1Sigma-Aldrich Co.
- Metabolic selection via asparagine biosynthesis pathway29 Jan 2026US 2026/0028611 A1Sigma-Aldrich Co.
- Pharmaceutical Composition for Treating or Preventing Disease Caused by Reduction or Deficiency in tm5U Modification31 Jul 2025US 2025/0242051 A1The University of Tokyo
Most cited
By later US patents
- Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism112US 6,743,823 B1Vanderbilt University · 2004
- Cell-free preparation of carbapenems13US 9,469,861 B2GreenLight Biosciences, Inc. · 2016
- Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto9US 6,346,382 B1Vanderbilt University · 2002
- Therapeutic methods employing nitric oxide precursors5US 8,188,147 B2Vanderbilt University · 2012
- Therapeutic methods employing nitric oxide precursors4US 8,536,225 B2Vanderbilt University · 2013